PA
AGN

Probity Advisors’s Allergan plc AGN Stock Holding History

Probity Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,941
Closed -$284K – 172
2019
Q1 		$284K Buy
1,941
+434
+29% +$62.9K 0.1% 142
2018
Q4 		$201K Sell
1,507
-1,032
-41% -$169K 0.07% 154
2018
Q3 		$484K Buy
2,539
+63
+3% +$11.6K 0.16% 112
2018
Q2 		$413K Buy
2,476
+169
+7% +$27.1K 0.15% 115
2018
Q1 		$388K Buy
2,307
+914
+66% +$153K 0.13% 110
2017
Q4 		$228K Buy
+1,393
New +$250K 0.08% 149

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Probity Advisors's AGN Position: Q2 2019 in Review

Probity Advisors sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 1,941 shares — an estimated $284K sold.

Probity Advisors first reported a position in AGN in Q4 2017 and held it in 6 quarters. The position peaked at $484K in Q3 2018. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Probity Advisors reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Probity Advisors sold 1,941 Allergan plc shares in Q2 2019, an estimated $284K.
  • Probity Advisors first reported a position in Allergan plc in Q4 2017 and held it in 6 quarters.
  • Probity Advisors's Allergan plc position peaked at $484K in Q3 2018.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Probity Advisors's 13F filing for Q2 2019, filed 8 Aug 2019.